Why should American headache and migraine patients still be treated with butalbital-containing medicine?

Headache

Volumn 52, Issue 4, 2012, Pages 672-674

  Tfelt Hansen, Peer Carsten ^a   Diener, Hans Christoph ^b  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BARBITURIC ACID DERIVATIVE; BUTALBITAL; BUTALBITAL PLUS CAFFEINE PLUS PARACETAMOL; BUTORPHANOL; CAFFEINE; NAPROXEN; NOSE SPRAY; OPIATE; PARACETAMOL; PLACEBO; SUMATRIPTAN;

ARTICLE; CLINICAL PRACTICE; DRUG DEPENDENCE; DRUG EFFICACY; DRUG MEGADOSE; HEADACHE; HUMAN; MIGRAINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); UNITED STATES;

ANALGESICS; BARBITURATES; CHEMISTRY, PHARMACEUTICAL; DRUG COMBINATIONS; HEADACHE; HUMANS; MIGRAINE DISORDERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; UNITED STATES;

EID: 84859702493     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2012.02115.x     Document Type: Article

References (10)

1. Derosier F, Sheftell F, Silberstein S, et al,. Sumatriptan-naproxen and butalbital, a double-blind, placebo-controlled crossover. Headache. 2011. [Epub ahead of print]. doi: 10.1111/j.1526-4610.2011.02039.x.
2. Silberstein SD, McCrory DC,. Butalbital in the treatment of headache: History, pharmacology, and efficacy. Headache. 2001; 41: 953-967.
3. Goldstein J, Gawel MJ, Winner P, et al,; on behalf of Stadol Nasal Spray/Fliorinal C Study Group. Comparison of butorphanol nasal spray and fiorinal with codeine in the treatment of migraine. Headache. 1998; 38: 516-522.
4. Silberstein SD,. Practice parameter: Evidence-based Guidelines for migraine headache (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000; 55: 754-762.
5. Wenzel RG, Sarvis CA,. Do butalbital-containing products have a role in the management of migraine? Pharmacotherapy. 2002; 22: 1029-1035.
6. Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB,. Transformed migraine and medication overuse in a tertiary centre-clinical characteristics and treatment outcome. Cephalalgia. 2004; 24: 483-490.
7. Loder E,. Fixed drug combinations for the acute treatment of migraine: Place in therapy. CNS Drugs. 2005; 19: 769-784.
8. Diener HC, Pfaffenrath V, Pageler L, Peil H, Aicher B,. The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: A multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia. 2005; 25: 776-787.
9. Diener H-C, Silberstein SD,. Medication overuse headaches. In:, Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA, eds. The Headaches, 3rd edn. Philadelphia, PA: Lippincott Williams & Wilkins; 2006: 971-979.
10. Diener HC, Wilkinson M, eds. Drug-Induced Headache. Berlin, Heidelberg, New-York: Springer; 1988.